Tariff Tsunami Hits Switzerland: Markets Bracing for Monday’s Trading Reopening
Swiss Stock Investors Prepare for Market Reopening Amid US Tariff Imposition
The Swiss stock market is bracing itself for Monday’s reopening after US President Donald Trump imposed a 39% export tariff on the country, one of the highest in the world. This move has left investors worried about the potential fallout, especially considering that the tariff rollout coincided with Switzerland’s National Day holiday.
The tariff rate is significantly higher than what many other countries are facing, and it’s likely to have a significant impact on the market. The 39% tariff rate will not only affect Swiss exporters but also create a competitive disadvantage for the country compared to its European Union counterparts, who secured a lower 15% tariff rate.
Impact of Tariffs on Swiss Exports
Switzerland is one of the US’s biggest trade partners, with over $60 billion worth of goods exported to the US last year. The exports include pharmaceuticals, medical devices, Nespresso coffee, and luxury watches from brands like Cartier and Chloé. With the 39% tariff rate, these exports will become more expensive for US consumers, which could lead to a decrease in demand.
The tariffs will also affect Swiss companies’ profits, as they will have to absorb the additional costs or pass them on to customers. This could lead to a decline in sales and revenue for Swiss companies, particularly those that are heavily exposed to the US market.
Market Reaction
On Friday, several US-listed Swiss stocks fell in response to the tariff announcement. UBS Group AG’s shares slid 1.8%, Logitech International SA dropped 3.5%, and Compagnie Financière Richemont SA’s American depositary receipts fell 2.5%. Watches of Switzerland Group Plc slumped 6.8% in London trading.
The market reaction was expected, given the significant impact that tariffs can have on trade relationships between countries. The Swiss Market Index has trailed the Stoxx 600 this year, partly due to its heavy exposure to defensive versus cyclical stocks. On Monday, the Swiss index could see a delayed reaction to its European peers, after the Stoxx 600 slumped 1.9% Friday for its worst day since April.
Negotiation Tactics or Final Say?
While some investors believe that the tariff imposition is just another negotiating ploy by Trump, others think it’s a serious attempt to pressure Switzerland into negotiations. Ipek Ozkardeskaya, senior analyst at Swissquote Group Holdings, said: "It’s hard to tell whether this is the final say — or it’s a negotiation tactic." Andrea Gabellone, head of global equities at KBC Global Securities, added: "This is hitting practically their core sectors — pharma, watches, chocolate, food. All those have already been hit by skyrocketing raw materials price and now this."
Pharmaceutical Sector Under Pressure
The tariff imposition on pharmaceuticals is particularly concerning for Swiss companies like Novartis AG and Roche Holding AG. Trump’s letters to 17 drugmakers last week demanding lower prices have already put pressure on the sector, with US and European peers dipping in response.
Arthur Jurus, Oddo BHF’s head of investment office Switzerland, wrote: "On top of the tariff strategy now comes a full-scale assault on the pricing of branded drugs sold in the US. Trump is applying unprecedented pressure on drug prices, directly targeting Swiss pharmaceutical giants."
What’s Next for Swiss Investors?
As the market prepares to reopen on Monday, investors will be closely watching the developments in Washington and Bern. While some believe that negotiations between Switzerland and the US are already underway, others think it’s too early to tell.
The impact of the tariffs on Swiss exports and companies’ profits will depend on how long the current tariff rate remains in place. If a deal is reached with the EU, similar to the one secured by its European Union counterparts, it could alleviate some pressure on Swiss exporters. However, even then, the 15% tariff rate would still be higher than before "Liberation Day," and the US dollar’s depreciation against the Swiss franc would make matters worse.
Conclusion
The imposition of a 39% export tariff by the US on Switzerland has left investors worried about the potential fallout for the market. The tariffs will likely create a competitive disadvantage for Swiss exporters compared to their European Union counterparts, who secured a lower 15% tariff rate. While some believe that negotiations between Switzerland and the US are already underway, others think it’s too early to tell.
As the market prepares to reopen on Monday, investors will be closely watching the developments in Washington and Bern. The impact of the tariffs on Swiss exports and companies’ profits will depend on how long the current tariff rate remains in place.
